To further elucidate the expression and significance of KAT8 in glioma tissues, we randomly selected 5 clinical tissue specimens of varying WHO grades (1 WHO grade I sample, 2 WHO grade III samples and 2 WHO grade IV samples), as well as 5 normal brain tissue samples obtained from epilepsy surgery. Here, KAT8 is linked to central nervous system cancer.